stop_circleTerminated/Withdrawn

Angiocardiography

Study of the X-ray contrast medium iotrolan 320 in angiocardiography in children up to 12 years of age

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

1 - 12 Years
  • -

  • -

Trial summary

Enrollment Goal
18
Trial Dates
May 1995 - September 1995
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Isovist (Iotrolan, BAY86-4879)
Accepts Healthy Volunteer
N/A

Trial design

Non-comparative open-label study of the X-ray contrast medium iotrolan 320 mg iodine/mL in angiocardiography in children up to 12 years of age
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A